Veru Inc (VERU)

Mar 13, 2025

VERU stock touches 52-week low at $0.47 amid market challenges - Investing.com

Mar 13, 2025

Mar 12, 2025

Here's Why Veru (VERU) Looks Ripe for Bottom Fishing - Yahoo Finance

Mar 12, 2025

Mar 10, 2025

Oppenheimer & Co. Inc. Boosts Stake in Veru Inc. (NASDAQ:VERU) - MarketBeat

Mar 10, 2025

Mar 07, 2025

B. Riley Cuts Price Target on Veru to $2 From $5, Keeps Buy Rating -March 07, 2025 at 07:49 am EST - Marketscreener.com

Mar 07, 2025

Mar 07, 2025

Veru Inc to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 06, 2025

Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround - Yahoo Finance

Mar 06, 2025

Mar 04, 2025

VERU stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada

Mar 04, 2025

Feb 27, 2025

Veru, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 24, 2025

Veru Inc. (NASDAQ:VERU) Director Acquires $52,403.45 in Stock - MarketBeat

Feb 24, 2025

Feb 21, 2025

Director Makes Bold Move with Major Veru Stock Purchase! - TipRanks

Feb 21, 2025

Feb 21, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire

Feb 21, 2025

Feb 20, 2025

3 US Penny Stocks With Market Caps Under $300M To Consider - Simply Wall St

Feb 20, 2025

Feb 20, 2025

Veru Inc. director Michael Rankowitz buys $84,350 in common stock - Investing.com

Feb 20, 2025

Feb 20, 2025

Veru Inc. director Michael Rankowitz buys $84,350 in common stock By Investing.com - Investing.com South Africa

Feb 20, 2025

Feb 20, 2025

Short Interest in Veru Inc. (NASDAQ:VERU) Rises By 14.3% - MarketBeat

Feb 20, 2025

Feb 18, 2025

Veru (NASDAQ:VERU) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat

Feb 18, 2025

Feb 17, 2025

Veru (NASDAQ:VERU) Issues Earnings Results - MarketBeat

Feb 17, 2025

Feb 17, 2025

Veru Inc. Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressVERU INC. (NASDAQ: VERU) recently released its financial results for the first quarter of fiscal 2025, along with key updates on its clinical development progr - Defense World

Feb 17, 2025

Feb 17, 2025

Earnings call transcript: Veru Inc Q1 2025 beats EPS forecast, stock dips - MSN

Feb 17, 2025

Feb 16, 2025

Veru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in January - Defense World

Feb 16, 2025

Feb 14, 2025

Oppenheimer Adjusts Price Target on Veru to $4 From $5, Keeps Outperform Rating - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

Veru Inc. (NASDAQ:VERU) Q1 2025 Earnings Call Transcript - Insider Monkey

Feb 14, 2025

Feb 14, 2025

Veru Inc Faces Uncertain Financial Future Amidst Lack of Revenue and Regulatory Hurdles - TipRanks

Feb 14, 2025

Feb 14, 2025

Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ... - Yahoo Finance

Feb 14, 2025

Feb 13, 2025

Veru Inc. Reports Strong Q1 Results and Clinical Progress - TipRanks

Feb 13, 2025

Feb 13, 2025

Veru Inc Earnings Call: Clinical Wins Amid Financial Concerns - TipRanks

Feb 13, 2025

Feb 13, 2025

Veru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatment - MSN

Feb 13, 2025

Feb 13, 2025

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress - GlobeNewswire

Feb 13, 2025

Feb 13, 2025

VERU INC. SEC 10-Q Report - TradingView

Feb 13, 2025

Feb 13, 2025

Veru Inc Reports Q1 EPS of -$0.01, Beating Estimates; Revenue Ma - GuruFocus.com

Feb 13, 2025

Feb 13, 2025

Earnings call transcript: Veru Inc Q1 2025 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa

Feb 13, 2025

Feb 13, 2025

Veru Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 13, 2025

Feb 13, 2025

Veru Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 6, 2023 to Discuss Your RightsVERU - Newsfile

Feb 13, 2025

Feb 13, 2025

Veru Inc. Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress - TradingView

Feb 13, 2025

Feb 13, 2025

Veru reports Q1 cont-op EPS (1c) vs. (8c) last year - TipRanks

Feb 13, 2025

Feb 13, 2025

Veru Inc. Reports Positive Phase 2b QUALITY Study Results and Announces New Indication for Sabizabulin in Atherosclerotic Coronary Artery Disease - Nasdaq

Feb 13, 2025

Feb 13, 2025

Game-Changing Clinical Results: Veru's Drug Outperforms Weight Loss Giant Wegovy in Muscle Protection - StockTitan

Feb 13, 2025

Feb 13, 2025

Veru Inc. (NASDAQ:VERU) Stock Position Boosted by SG Americas Securities LLC - Defense World

Feb 13, 2025

Feb 12, 2025

Veru Inc (VERU) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus.com

Feb 12, 2025

Feb 11, 2025

Nine Energy Service Inc Inc. (NINE) Price Performance Over the Years: A Comparative Study - The InvestChronicle

Feb 11, 2025

Feb 10, 2025

Trading Day Review: Veru Inc (VERU) Loses Momentum, Closing at 0.56 - The Dwinnex

Feb 10, 2025